Abstract
The use of high flow oxygen therapy (Optiflow®) is increasing, but clear indications are lacking. This pragmatic review describes the current evidence for the use of high flow oxygen therapy in the intensive care unit in three different patient populations: Acute hypoxaemic respiratory failure, (prevention of) post-extubation failure and during interventions.
Original language | English |
---|---|
Pages (from-to) | 225-228 |
Number of pages | 4 |
Journal | Netherlands Journal of Critical Care |
Volume | 27 |
Issue number | 6 |
Publication status | Published - 1 Nov 2019 |
Keywords
- Acute respiratory failure
- High flow nasal cannula
- High flow oxygen therapy
- Nasal high flow therapy
- Post-extubation failure